| | Other Issues: previous | next | latest | archiveReview Societal costs of air pollution-related health hazards: A review of methods and results Tanjima Pervin, Ulf-G Gerdtham, and Carl Hampus Lyttkens PMCID: PMC2553058 Research Dynamic effects of smoking cessation on disease incidence, mortality and quality of life: The role of time since cessation Rudolf T Hoogenveen, Pieter HM van Baal, Hendriek C Boshuizen, and Talitha L Feenstra PMCID: PMC2267164 Integrating tuberculosis and HIV services for people living with HIV: Costs of the Zambian ProTEST Initiative Fern Terris-Prestholt, Lilani Kumaranayake, Rokaya Ginwalla, Helen Ayles, Ignatius Kayawe, Mary Hillery, and Peter Godfrey-Faussett PMCID: PMC2266707 The cost of antiretroviral therapy in Haiti Serena P Koenig, Cynthia Riviere, Paul Leger, Patrice Severe, Sidney Atwood, Daniel W Fitzgerald, Jean W Pape, and Bruce R Schackman PMCID: PMC2276481 Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis Shalini L Kulasingam, Steve Benard, Ruanne V Barnabas, Nathalie Largeron, and Evan R Myers PMCID: PMC2290741 Could CT screening for lung cancer ever be cost effective in the United Kingdom? David K Whynes PMCID: PMC2292150 Does productivity influence priority setting? A case study from the field of CVD prevention Lars Lindholm, Emil Löfroth, and Måns Rosén PMCID: PMC2291028 S4HARA: System for HIV/AIDS resource allocation Arielle Lasry, Michael W Carter, and Gregory S Zaric PMCID: PMC2386442 Is the value of a life or life-year saved context specific? Further evidence from a discrete choice experiment Duncan Mortimer and Leonie Segal PMCID: PMC2409302 Review of Australian health economic evaluation – 245 interventions: what can we say about cost effectiveness? Kim Dalziel, Leonie Segal, and Duncan Mortimer PMCID: PMC2413209 Formulas for estimating the costs averted by sexually transmitted infection (STI) prevention programs in the United States Harrell W Chesson, Dayne Collins, and Kathryn Koski PMCID: PMC2426671 Non-pharmaceutical prevention of hip fractures – a cost-effectiveness analysis of a community-based elderly safety promotion program in Sweden Pia Johansson, Siv Sadigh, Per Tillgren, and Clas Rehnberg PMCID: PMC2440733 Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration Susan F Hurley, Jane P Matthews, and Robyn H Guymer PMCID: PMC2443361 Decision maker views on priority setting in the Vancouver Island Health Authority Francois Dionne, Craig Mitton, Neale Smith, and Cam Donaldson PMCID: PMC2507702 Setting priorities for the health care sector in Zimbabwe using cost-effectiveness analysis and estimates of the burden of disease Kristian Schultz Hansen and Glyn Chapman PMCID: PMC2517588 Are there differences between unconditional and conditional demand estimates? implications for future research and policy Budi Hidayat PMCID: PMC2546365 People's willingness to pay for health insurance in rural Vietnam Curt Lofgren, Nguyen X Thanh, Nguyen TK Chuc, Anders Emmelin, and Lars Lindholm PMCID: PMC2527552 The costs of traumatic brain injury due to motorcycle accidents in Hanoi, Vietnam Hanh TM Hoang, Tran L Pham, Thuy TN Vo, Phuong K Nguyen, Christopher M Doran, and Peter S Hill PMCID: PMC2538497 Cost-effectiveness of smoking cessation to prevent age-related macular degeneration Susan F Hurley, Jane P Matthews, and Robyn H Guymer PMCID: PMC2562365 Community-based DOTS and family member DOTS for TB control in Nepal: costs and cost-effectiveness Tolib N Mirzoev, Sushil C Baral, Deepak K Karki, Andrew T Green, and James N Newell PMCID: PMC2596781 |
